Chugai settles cancer drug patent dispute with US firm

10-08-2022

Staff Writer

Chugai settles cancer drug patent dispute with US firm

OleksandrShnuryk / Shutterstock.com

Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.


Chugai, Fresenius Kabi, patent infringement, ANDA, generics, Roche, Genentech, Alecensa, cancer drug

LSIPR